Judge Allows Fraudulent Concealment Claims to Proceed in Neurontin MDL

BOSTON - A Massachusetts federal judge has refused to dismiss certain fraudulent concealment claims brought in the Neurontin multidistrict litigation, finding that the plaintiffs adequately pled that defendant drug makers intentionally withheld material information about the side effects of Neurontin from both consumers and their prescribing physicians, with the intent to deceive. In re Neurontin Marketing, Sales Practices and Products Liability Litigation, MDL No. 1629 (D. Mass.).

However, in the May 26 order, Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts dismissed all fraud claims alleging affirmative misrepresentations or a suppression of information as …